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Debridement is a crucial component of wound management. Recent technologies such as 
hydrosurgery (Versajet), ultrasound therapy (the MIST therapy device), or plasma-mediated 
bipolar radio-frequency ablation therapy (Coblation) seem to represent interesting alterna-
tives for wound debridement. The purpose of this systematic review was to describe, evaluate, 
and compare these three recently developed methods for the management of chronic 
wounds. In January 2016, an electronic database search was conducted of MEDLINE, PubMed 
Central, and Embase for articles concerning these three innovative methods for the manage-
ment of chronic wounds. A total of 389 references were identified by our search strategy, and 
15 articles were included. We extracted data regarding the number and age of patients, indi-
cations, operating time, number of procedures, costs, wound healing time, decrease in exuda-
tion, perioperative blood loss, bacterial load, and the occurrence of complications. The 15 ar-
ticles included studies that involved 563 patients who underwent hydrosurgery (7 studies), 
ultrasound therapy (6 studies), or Coblation (2 studies). Six randomized controlled trials were 
included that compared the use of a scalpel or curette to hydrosurgery (2 studies) or ultra-
sound therapy (6 studies). Hydrosurgery, in addition to being a very precise and selective tool, 
allows significantly faster debridement. Ultrasound therapy provides a significant reduction 
of exudation, and improves the wound healing time. No comparative study dedicated to Co-
blation was identified. Despite the obvious clinical interest of the topic, our review of the cur-
rent literature revealed a lack of prospective randomized studies comparing these devices 
with each other or with standard techniques, particularly for Coblation and hydrosurgery.
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INTRODUCTION
Wound debridement consists of removing necrotic or devital-
ized tissue and reducing the bacterial load. It is an essential step 
to bring about wound healing. Numerous debridement meth-
ods exist, such as autolytic [1], enzymatic [2], biodebridement 
[3], and surgical/sharp [4] and mechanical methods. Although 
sharp debridement using a scalpel or curette remains the gold 
standard [4], these techniques have several disadvantages. They 
are not appropriate for large surfaces, are not optimal for saving 
tissue, and they often lead to an uneven wound bed. 
Recent innovations, such as hydrosurgery (Versajet) [5], ultra-
sound therapy (the MIST therapy device), [6] and plasma-me-
diated bipolar radio-frequency ablation therapy (Coblation) [7] 
could represent an alternative to conventional debridement in 
many cases, especially for chronic non-healing wounds. Those 
methods remain more expensive, but could be seen as more ef-
ficient than conventional techniques. The purpose of this sys-
tematic review was to describe and compare these three recently 
developed methods and to identify the particular benefits of 
each device.
MATERIALS
We compared three recently developed methods for wound 
management: hydrosurgery (Versajet hydrosurgery system), ul-
trasound (the MIST therapy device), and plasma-mediated bi-
polar radio-frequency ablation (Coblation).
Hydrosurgery
The Versajet hydrosurgery system (Smith & Nephew, London, 
UK) is a hydrosurgical device based on the principle of the Ven-
turi effect. Saline solution is forced through a narrow window at 
high velocity, creating a localized vacuum. The suction permits 
targeted tissue to be cut while aspirating debris from the site 
(Supplemental Video S1).
Ultrasound
The MIST therapy device (Celleration, Eden Prairie, MN, 
USA) is intended to promote healing in chronic wounds. The 
manufacturer claims that the atomized saline acts as a conduit 
for ultrasound waves to reach the treatment site and that wound 
healing is promoted through debridement (i.e., the removal of 
fibrin, tissue exudates, and bacteria) (Supplemental Video S2).
Plasma-mediated bipolar radio-frequency ablation 
Coblation (Arthrocare ENT, Austin, TX, USA) uses bipolar ra-
dio-frequency to energize molecules via a conductive solution 
surrounding an active electrode, which creates a precisely fo-
cused plasma field. The glow discharge plasma produces chemi-
cally active radical species from the dissociation of water, break-
ing molecular bonds and causing tissue dissolution (Supple-
mental Video S3).
METHODS
Study design
A systematic review of the literature was conducted using the 
MEDLINE, PubMed Central, and Embase databases. The re-
search period was not limited. This review was conducted in 
line with the recommendations specified in the Cochrane 
Handbook for Systematic Reviews of Interventions version 
5.1.0, was AMSTAR-compliant, and was reported in accordance 
with the Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) statement. Informed consent was ob-
tained from the patient or informed consent have been waived.
Inclusion criteria
All original studies describing hydrosurgery, ultrasound therapy, 
or plasma-mediated bipolar radio-frequency ablation were in-
cluded. Duplicate studies, review articles, editorial/discussions/
commentaries, letters, purely technical descriptions, and animal 
studies were excluded.
Search strategy
In January 2016, an electronic database search was conducted of 
MEDLINE, PubMed Central, and Embase. This search was 
conducted using appropriate keywords in the English language 
with Boolean logical operators as follows: “Versajet” OR “Hy-
drosurgery” [Title/Abstract/MeSH Terms], “Arthrocare” OR 
“Plasma-mediated bipolar radio-frequency ablation” OR “Co-
blation technology” OR “Bipolar radio-frequency plasma” OR 
“Electrochemical debridement” [Title/Abstract/MeSH 
Terms], “Ultrasonic” OR “Ultrasonic MIST therapy” OR “Non-
contact low frequency” [Title/Abstract/MeSH Terms]. There 
were no limits on research; non-English articles were translated, 
including Chinese articles. Data concerning only burns were ex-
cluded.
Data extraction
Data extraction was performed independently by two research-
ers (FB and JV) and discrepancies were resolved by consensus. 
If this was not possible, one of the senior authors (CH) was 
asked to make the final decision. The extracted data were the 
number and age of patients, indications, operating time, number 
of procedures, and complications. The methodological quality 
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of studies was assessed using the levels of evidence defined by 
the Oxford Centre for Evidence-Based Medicine [8].
Practical approach
The analysis of this review and the extrapolation of our experi-
ence with these three procedures have allowed us to identify a 
practical approach.
RESULTS
A total of 389 references were identified by our search strategy, 
including seven studies of hydrosurgery, six of ultrasound, and 
two of plasma-mediated bipolar radio-frequency ablation that 
met our criteria for inclusion. Fig. 1 shows how studies were se-
lected through the processes of identification, screening, and eli-
gibility, with 15 studies [9-23] finally included in this review. 
Population 
The 15 articles included studies that involved 563 patients (Ta-
ble 1). We analyzed seven articles [9-15] investigating hydrosur-
gery, including 255 patients with an average age of 56.1 years 
(range, 1–79 years). The level of evidence was low to moderate. 
For ultrasound therapy, six articles [16-21] were screened. A to-
tal of 296 patients with an average age of 68.1 years (range, 40–
78 years) were treated. One study [16] had a high level of evi-
dence (Table 2). Concerning Coblation therapy, only two arti-
cles [22,23] were selected, including 31 patients. The level of 
evidence was low.
Procedures
For hydrosurgery, one procedure was performed for 86.3% of 
patients (220/255) and several procedures were necessary for 
13.7% (35/255). For ultrasound therapy, the number of re-
quired procedures was highly variable across studies, ranging 
from 1 to 10. Finally, for Coblation therapy, in most of the cases, 
one procedure was necessary (Table 1).
Operating time
Caputo et al. [10] found that on an average, hydrosurgery de-
bridement was significantly faster than classic sharp debride-
ment (10.8 minutes vs. 17.7 minutes). Gurunluoglu [9] gave a 
mean time to debride the wound of 15.5 minutes, but these re-
sults were not accompanied by data regarding the surface area of 
the wounds. For ultrasound therapy, the operating time varied 
depending on the team [16-20], ranging from 3 to 20 minutes. 
No data were found for Coblation therapy (Tables 2 and 3).
Cost efficiency
Concerning hydrosurgery, the authors [10,14] emphasized the 
indirect financial gains of saving operating time, which allowed 
the treatment of more patients in the same operating schedule. 
The financial analysis of ultrasound therapy by Honaker et al. 
Fig. 1. Flow chart of article research and inclusion
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387 Records identified through 
PubMed database searching
389 Records after duplicates removed
153 Duplicates removed
370 Records excluded
4 Full-text articles excluded, 
with reasons
2 No orginal data
1 Pure technical note
1 Review
389 Records screened
19 Full-text articles assessed for eligibility
15 Studies included in qualitative synthesis
15 Studies included in quantitative synthesis
2 Additional records identified 
through other sources
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[20] did not show any significant gain. No data were found for 
Coblation therapy (Table 3).
Bacterial load
In our review, bacterial load was examined only for hydrosur-
gery, in the study by Liu et al. [14]. There was no significant dif-
ference in the quantitative bacterial counts (P = 0.376) (Tables 
2 and 3).
Blood loss 
Vanwijck et al. [12], in a series of 167 sub-acute and chronic 
wounds, described one instance of perioperative bleeding, 
which was easily controlled. No data were found for ultrasound 
therapy. Trial et al. [23] emphasized the advantage of a reduc-
tion in bleeding when coagulation was employed (Table 3).
Healing capacity 
Concerning hydrosurgery, two single-center prospective ran-
domized trials [10,14] compared hydrosurgery performed on 
40 patients to conventional debridement performed on 41 pa-
tients. Neither study highlighted a significant shortening of 
wound healing time with hydrosurgery compared to traditional 
techniques (Tables 2 and 3).
For ultrasound therapy, two prospective randomized [16,19] 
and two retrospective non-randomized [18,20] trials compar-
ing ultrasound therapy were analyzed. These studies involved 
241 patients who received ultrasound and 142 who received 
standard care. Ennis et al. [16] compared ultrasound therapy to 
placebo in diabetic patients with foot ulcers in a randomized, 
multicenter, double-blinded study. At 12 weeks, they reported 
significantly higher healing rates in the treatment group. Kavros 
et al. [18] reported similar results in patients with leg ulcers as-
Technique Study (year) Grade No. of patients Age (yr)
a) Indication Procedure Operative time (min)b) Complications
Hydrosurgery Gurunluoglu, 2007 [9]  C  15 39.1 Traumatic (n=10) 15.5 Incomplete graft take (n=3)
Ulcer (n=2) 1 (n=10)
Pressure sore (n=1) 2 (n=4)
Burn (n=1) 3 (n=1)
Infectious (n=1)
Caputo et al., 2008 [10] B  19 68 Ulcer 1 (n=21) 10.8 No
2 (n=1)
Dillon et al., 2010 [11] C    6 26.3 Infectious 1 ND No
Vanwijck et al., 2010 [12] C 167 56 Ulcer (n=122) 1 ND Incomplete graft take (n=8)
Pressure sore (n=28)
Traumatic (n=13)
Infectious (n=4)
Fraccalvieri et al., 2011 [13] B  27 69.4 Ulcer (n=16) 1 ND No
Infectious (n=6)
Pressure sore (n=5)
Liu et al., 2015 [14] B  21 52.2 Ulcer (n=17) 1 14.2 No
Dehiscence (n=3)
Traumatic (n=1)
Sivrioglu et al., 2014 [15] C   9 2.5 Extravasation injury 1 ND No
Ultrasound Ennis et al., 2005 [16] A  55 ND Ulcer 3/wk 4 No
Ennis et al., 2006 [17] C  23 61.1 Ulcer 3/wk 3–12 No
Kavros et al., 2008 [18] C 163 70.6 Ulcer 3/wk 3–20 No
Yao et al., 2014 [19] B   8 58 Ulcer 1–3/wk 5 No
Honaker et al., 2013 [20] C  85 72 Pressure sore 10 3–20 No
Jeffers et al., 2014 [21] C  4 ND Post-surgical 5–9 ND ND
Coblation Richards et al., 2012 [22] C  6 ND Ulcer (n=5) 1 ND No
Pressure sore (n=1) 1
Trial et al., 2012 [23] C 25 ND Burns (n=15) 1 ND Incomplete graft take (n=1)
Ulcer (n=4)
Pressure sore (n=3)
ND (n=3)
A, B, C correspond of grade of recommendation (evidence-based medicine).
ND, no determined.
a)Mean; b)Average operating time of the procedure.
Table 1. Characteristics of included studies
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sociated with chronic critical limb ischemia. Yao et al. [19] 
showed a reduction in the percentage of wound area when pa-
tients received ultrasound therapy three times a week compared 
to standard care (Tables 2 and 3). 
No study investigated the healing time associated with Cobla-
tion therapy.
DISCUSSION
The ideal debridement method should improve tissue sparing, 
be easy to use even in deep wounds, allow the debridement to 
be completed quickly, not be hemorrhagic, have a low relative 
cost compared to repeated dressings, decrease the bacterial load, 
and improve the global healing rate.
Five debridement methods are currently used: autolytic [1], 
enzymatic [2], biological [3], surgical/sharp [4], and mechani-
cal methods. Autolytic, enzymatic, and biological methods are 
selective, but are time-consuming and may cause the destruc-
tion of adjacent tissues. Autolytic debridement, which is the 
body’s natural response to necrotic tissue, is painless and selec-
tive, but the process is slow [24]. Enzymatic debridement has 
been suggested as an alternative method, and is useful when 
other techniques are not feasible during the initial management 
of a chronic wound [2]. Recently, biodebridement using mag-
gots has become increasingly popular. Larval therapy can be 
highly selective and rapid [3]. Sharp debridement (scalpel or 
curette) is the current gold standard [4]. This method is faster 
but not selective, because it may also remove healthy tissue. 
This technique is also more hemorrhagic and painful. Finally, 
mechanical debridement requires a competent practitioner with 
specialist training, and a hospital admission is necessary [25].
Recently, three innovative methods have emerged: hydrosur-
gery (Versajet) [5], ultrasound therapy (MIST therapy) [6], 
and plasma-mediated bipolar radio-frequency ablation (Cobla-
tion therapy: Arthrocare) [7]. 
Hydrosurgery (Supplemental Video S1) has been described as 
Technique Study (year) Type of studies
Gold standard: 
scalpel or 
curette
News 
therapies Result
Hydrosurgery Caputo et al., 2008 [10] Unicentric
Prospective
Randomized
22 19 Significant evidence of a shorter time debridment (10.8 min) using Versajet 
over conventional debridment (17.7 min) (P<0.008). 
Median time to wound closure 71 day (Versajet) vs. 74 day (conventional) 
(P=0.733).
Liu et al., 2015 [14] Unicentric
Prospective
Randomized
19 21 No significant difference in terms of cost (P=0.28). 
No significant difference in time to achieve stable wound closure (P=0.77). 
No difference in quantitative bacterial counts (P=0.376).
Ultrasound Ennis et al., 2005 [16] Multicentric
Prospective 
Randomized 
28 27 Significant reduction in the exudation at wk 5 (P=0.001). 
Mean time to healing shorther in group using ultrasound therapy (9.12 wk) 
compare to control (11 wk) (P=0.0366). 
Proportion of wounds healed at wk 12 is higher in ultrasound group (40.7%) 
compared to group (14.3%) (P=0.0366).
Kavros et al., 2008 [18] Unicentric
Retrospective
Non randomized
47 163 A significant rates of healing in ischemic (P=0.049), neuropathy (P=0.08) 
and venous (P=0.02) wounds.
Yao et al., 2014 [19] Unicentric
Prospective
Randomized
4 8 No statistically significant difference.
Honaker et al., 2013 [20] Unicentric
Retrospective
Non randomized
63 43 Significant decrease in wound severity between groups for the discharge 
assessment (P<0.005).
Table 2. Randomized controlled trials
Technique Operative time Cost efficiency Bacterial load Blood loss Healing capacity
Hydrosurgery +++ + [10,14] ++ [14] No data ++ [10,14]
Ultrasound + [16,20] ++ [20] No data No data +++ [16,18,19]
Coblation No data No data No data + [23] No data
+, data without statistic test; ++, no statistically significant P>0.05; +++, statistically significant P<0.05.
Table 3. Summary of articles analyzed 
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an appropriate debridement technique for burns [26,27], ve-
nous leg ulcers [28], and pressure ulcers [24]. The Versajet hy-
drosurgery system is a hydrosurgical device based on the princi-
ple of the Venturi effect. In wound debridement, the benefits of 
irrigation in terms of reducing the bacterial load are well recog-
nized. The wound is flushed with saline solution (at 118–300 
m/s and 103–827 bar, depending on the 10-step speed setting 
on the console) to simultaneously remove dead tissue and dilute 
the bacterial load. The cutting effects can also be manipulated 
by adjusting the hand piece orientation and pressure, with high 
precision [28].
Caputo et al. [10] presented significant evidence of shorter 
debridement times (10.8 minutes) using Versajet over conven-
tional debridement (17.7 minutes). No significant difference in 
time to achieve stable wound closure and no difference in quan-
titative bacterial counts (P = 0.376) were found in the study by 
Liu et al. [14]. This device is interesting for dry necrosis, and ac-
cording to Klein et al. [5], the device using the Venturi effect 
seemed to be more conservative than Coblation [5]. 
In our own experiences, we have observed the Venturi effect 
to be very effective on dry fibrin and necrotic tissue, but it does 
not allow hemostasis, limiting its use for large and hemorrhagic 
wounds. 
Ultrasound-based MIST therapy (Supplemental Video S2) 
devices deliver energy of 0.1 to 0.5 W/cm2 within the scope of 
defined treatment. The currently available literature suggests 
that low-frequency ultrasound is capable of stimulating cellular 
activity through mechanical energy in the absence of key growth 
factors, ATP, cytokines, or other enzymes [20]. Signal transduc-
tion pathways can be stimulated by ultrasound-generated me-
chanical energy [16]. MIST ultrasound therapy has been shown 
to enhance angiogenesis and collagen deposition in a diabetic 
mouse model [29]. Two phenomena relevant to the mecha-
nisms of ultrasound therapy have been identified: acoustic cavi-
tation and acoustic microstreaming. Acoustic cavitation de-
scribes conformational changes caused by the mechanical ener-
gy from an ultrasound wave that is absorbed by individual pro-
tein molecules [30]. Cavitation occurs with the production and 
vibration of micron-sized bubbles formed in the tissues, which 
lead to changes in cell function [31]. Acoustic microstreaming 
occurs when fluids move along sound wave boundaries, such as 
cell membranes, resulting in increased protein synthesis and in-
creased permeability of the cell membranes and vascular walls 
[32]. More research is needed to fully elucidate the mechanisms 
by which ultrasound energy may contribute to the tissue repair 
process on a cellular level.
A study of MIST therapy by Ennis et al. [16] showed a signifi-
cant reduction in exudation at week 5 (P = 0.001). Furthermore, 
the mean time to healing was shorter in the group using ultra-
sound therapy (9.12 weeks) than in the control group (11 
weeks) (P = 0.0366), and a higher proportion of wounds had 
healed by week 12 in the ultrasound group (40.7%) than in the 
control group (14.3%) (P = 0.0366). Of the 133 initially en-
rolled patients, 55 were finally analyzed. In an intention-to-treat 
analysis, no statistically significant difference was found [16]. 
MIST therapy is easy to use and fast; the average time varied be-
tween 3 minutes and 20 minutes [18-20]. Unpublished animal 
studies demonstrating bacterial disruption after ultrasound 
therapy were confirmed by scanning electron microscopy. The 
indications for MIST therapy appear to be simple wounds, with 
a low density of fibrin, a low risk of bleeding, and some small-ar-
ea infected wounds. It is thus particularly useful in diabetic pa-
tients. This technique is especially relevant for ambulatory pa-
tients who require a minimum of three sessions per week [19] 
for faster wound healing. The technique is very simple and can 
be performed by nurses.
Concerning plasma-mediated bipolar radio-frequency abla-
tion therapy (Supplemental Video S3), few articles have been 
published. Conventional electrosurgical devices are based on 
principles described in 1909 [33]. The original technique used 
a high current density, generating very high temperatures capa-
ble of disintegrating tissue through a pyrolytic process [34]. Co-
blation uses bipolar radio-frequency to energize molecules via a 
conductive solution surrounding the active electrode, thus cre-
ating a precisely focused plasma field. This plasma wire is offset 
by approximately 0.5 mm from the wand tip, enabling a regular 
debridement depth. Currently, no randomized controlled trials 
have been published [23]. One study is still in progress 
(NCT00534781), but no results are available. The importance 
of biofilms and bacterial colonization in relation to impaired 
wound healing is receiving significant scientific and clinical at-
tention [35]. In an in vitro study, Sonnergren et al. [36] showed 
significant microbicidal effects compared to hydrosurgery or 
standard debridement. The reduction compared with untreated 
controls was 99.87% to 99.99% (P < 0.0001) for all strains 
(Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas ae-
ruginosa, Escherichia coli and Candida albicans). In contrast to 
hydrosurgery, there is no risk of spreading aerosolized bacteria 
[37], so health personnel are less exposed to bacterial contami-
nation in the air. Coblation provides a hemostatic effect [23], 
which is particularly interesting for chronic inflammatory 
wounds and for patients receiving anticoagulant therapy. It is 
appropriate for the preparation of skin grafts and causes no 
bleeding, thus allowing a one-time closure. The Coblation tech-
nology may be indicated for any type of debridement involving 
fibrotic and fatty necrosis debridement and wound bed prepara-
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tion [23]. In our experience [23], this device was most useful 
for fibrotic, infected, and hemorrhagic wounds. This instrument 
has gradually replaced the use of hydrosurgery. It also seems to 
us to be more accurate and more convenient than hydrosurgery. 
However, the wear of the filaments limits its use for wounds of 
which the surface is less than 5% of the total body surface.
The treatment cost for the MIST therapy system is US dollar 
(USD) 9,870 per patient for 26 weeks based on three treat-
ments per week. The rental cost per treatment was estimated to 
be USD 8, assuming that one MIST therapy system would be 
used on five patients per day for 5 days a week. Its consumables 
cost was calculated to be USD 45 per treatment. The treatment 
cost for MIST therapy also included wound dressing costs at 
USD 9 per treatment and nursing time at USD 65 per visit. The 
cost of a Versajet console was USD 7,500 to 9,000, and each 
hand piece was USD 300. It has been estimated by the manufac-
turer that the cost per treatment was USD 340 for the technolo-
gy and USD 550 for staff and operating theater time. Compara-
tively, the cost of a Coblation console was USD 4,000 and that 
of a hand piece was USD 500.
PRACTICAL APPROACH
The analysis of this review and the extrapolation of our experi-
ence concerning hydrosurgery (150 procedures), Coblation 
(200 procedures), and ultrasound therapy (50 procedures) have 
allowed us to identify a practical approach:
- Coblation therapy seems to be particularly useful for dry fi-
brotic, infected, and bleeding wounds, typically chronic ulcers 
or small deep burns. 
- Hydrosurgery can be used for infected [13], fibrinous [5] 
wounds and intermediate-depth and large burns.
- Finally, ultrasound seems useful in wounds with a low density 
of fibrin, a low risk of bleeding, and a small infected area, as in 
diabetic foot ulcer lesions or small leg ulcers that require fre-
quent attention, often from a nurse. 
We summarize these indications in Fig. 2. 
Our study had several limitations. First, no study included in 
this review compares the three techniques, and the practical ap-
proach was developed based on our own experiences, without 
specific scientific evidence.
CONCLUSIONS
Compared to standard debridement techniques with a scalpel 
or curette, ultrasound therapy showed a significant reduction in 
healing time and a shorter operating time, which may be associ-
ated with an indirect financial gain. No comparative study dedi-
cated to Coblation was identified. 
This systematic review highlighted the progress of these three 
methods and proposed an optimal use for each based on our 
personal experiences. However, further randomized controlled 
trials are needed to evaluate and compare these three innovative 
techniques.
NOTES
Conflict of interest
No potential conflict of interest relevant to this article was re-
ported.
Patient consent
The patients provided written informed consent for the publica-
tion and the use of their images.
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